[1] National Cancer Institute. Cancer Stat Facts: Colorectal Cancer. Surveillance, Epidemiology, and End Results Program. Available at: https://seer.cancer.gov/statfacts/html/colorect.html
[2] American Cancer Society. Survival Rates for Colorectal Cancer. Available at: https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/survival-rates.html
[3] Tsilimigras DI, Ntanasis-Stathopoulos I, Pawlik TM. Molecular Mechanisms of Colorectal Liver Metastases. Cells. 2023;12(12):1657. doi: 10.3390/cells12121657. PMID: 37371127.
[4] Hapach LA, Mosier JA, Wang W, Reinhart-King CA. Engineered models to parse apart the metastatic cascade. npj Precision Oncology. 2019;3:20. doi: 10.1038/s41698-019-0092-3.
[5] Bürtin F, Mullins CS, Linnebacher M. Mouse models of colorectal cancer: Past, present and future perspectives. World Journal of Gastroenterology. 2020;26(13):1394-1426. doi: 10.3748/wjg.v26.i13.1394. PMID: 32308343.
[6] Bocuk D, Wolff A, Krause P, Salinas G, Bleckmann A, Hackl C, Beissbarth T, Koenig S. The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model. BMC Cancer. 2017;17(1):342. doi: 10.1186/s12885-017-3342-1. PMID: 28525976.
[7] Lee JR, Kwon CH, Choi Y, Park HJ, Kim HS, Jo HJ, Oh N, Park DY. Transcriptome analysis of paired primary colorectal carcinoma and liver metastases reveals fusion transcripts and similar gene expression profiles in primary carcinoma and liver metastases. BMC Cancer. 2016;16:539. doi: 10.1186/s12885-016-2596-3. PMID: 27461012.
[8] Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Research. 2019;47(W1):W556-W560. doi: 10.1093/nar/gkz430. PMID: 31114875.
[9] Andrews S. FastQC: A quality control tool for high throughput sequence data. Available at: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/
[10] Krueger F. Trim Galore: A wrapper tool around Cutadapt and FastQC to consistently apply quality and adapter trimming to FastQ files. Available at: https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/
[11] Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Research. 2002;12(6):996-1006. doi: 10.1101/gr.229102.
[12] Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15-21. doi: 10.1093/bioinformatics/bts635.
[13] Harvard Chan Bioinformatics Core (HBC). Introduction to RNA-Seq using high-performance computing [archived]. Available at: https://hbctraining.github.io/Intro-to-rnaseq-hpc-O2/. RRID:SCR_025373.
[14] Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923-930. doi: 10.1093/bioinformatics/btt656.
[15] Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Research. 2012;22(9):1760-1774. doi: 10.1101/gr.135350.111.
[16] Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8.
[17] Mistry M, Piper M, Liu J, Khetani R. hbctraining/DGE_workshop_salmon_online: Differential Gene Expression Workshop Lessons from HCBC (first release). Zenodo. 2021. https://doi.org/10.5281/zenodo.4783481. RRID:SCR_025373.
[18] Stephens M. False discovery rates: a new deal. Biostatistics. 2017;18(2):275-294. doi: 10.1093/biostatistics/kxw041.
[19] Blighe K, Rana S, Lewis M. EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling. Bioconductor. Available at: https://bioconductor.org/packages/EnhancedVolcano/
[20] Kolde R. pheatmap: Pretty Heatmaps. R package. Available at: https://CRAN.R-project.org/package=pheatmap
[21] Teng S, Li YE, Yang M, et al. Tissue-specific transcription reprogramming promotes liver metastasis of colorectal cancer. Cell Research. 2020;30(1):34-49. doi: 10.1038/s41422-019-0259-z.
[22] Ben-David U, Siranosian B, Ha G, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. 2018;560(7718):325-330. doi: 10.1038/s41586-018-0409-3.
[23] Ray T, Ryusaki T, Ray PS. Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis. Frontiers in Oncology. 2021;11:721959. doi: 10.3389/fonc.2021.721959. PMID: 34540690.
[24] Pérez-González A, Bévant K, Blanpain C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nature Cancer. 2023;4(8):1063-1082. doi: 10.1038/s43018-023-00595-y. PMID: 37537300.
[25] Chatterjee S, Behnam Azad B, Nimmagadda S. The Intricate role of CXCR4 in cancer. Advances in Cancer Research. 2014;124:31-82. doi: 10.1016/B978-0-12-411638-2.00002-1. PMID: 25287686.
[26] Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ, Hoon DSB. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. Journal of Clinical Oncology. 2005;23(12):2744-2753. doi: 10.1200/JCO.2005.07.078. PMID: 15837989.